Bod Science Ltd (ASX: BOD) Share Price and News

Price

$0.024

Movement

0.00 (0.0)

as at 24 Apr - Closed (20 mins delayed)

52 Week Range

-

 
1 Year Return

0.0

Bod Science Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $4.26 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 177.34 million
Earnings per share -0.037
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

$0.024

Day Change

0.00 (0.0)

52 Week Range

-

Yesterday's Close

$0.024

Today's Open

Days Range

-

Volume

0

Avg. Volume (1 month)

0

Turnover

$0

as at 24 Apr - Closed

Bod Science Ltd (ASX: BOD)
Latest News

Healthcare Shares

Why a COVID-19 trial is exciting BOD (ASX:BOD) investors today?

A clinical trial into the use of medicinal cannabis for long-term COVID-19 is going ahead.

Read more »

three excited doctors with hands in the air
Share Gainers

These 3 ASX Healthcare shares are running hot today

These ASX Healthcare shares have led the way today along with metals and mining.

Read more »

women working with medicinal marijuana, indicating a share price movement in ASX cannabis shares
Share Market News

Why the Bod (ASX:BDA) share price is climbing today

This ASX cannabis stock is on the rise today after a promising sales update

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Cannabis Shares

Up 21%, why the Bod (ASX:BDA) share price is smoking the market today

The Bod (ASX: BDA) share price has surged 21% today following the release of a positive trading update. Here's what…

Read more »

A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares
Share Market News

Bod (ASX:BDA) share price soars on United States market entry

The Bod Australia Ltd (ASX: BDA) share price is soaring after the company announced its first purchased order for the…

Read more »

little green pharma share price represented by cannabis leaf character jumping cheerfully
Share Market News

Why the Bod (ASX:BDA) share price is tracking 5% higher today

The Bod Australia Ltd (ASX: BDA) share price is up more than 5% today following the release of a positive…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
Share Market News

Why the Bod (ASX:BDA) share price is soaring 11%

The Bod share price is soaring 12% today as the company announced strong sales in the second half of CY2020.

Read more »

hand on touch screen lit up by a share price chart moving higher
Share Gainers

Why Atomos, BOD Australia, Galaxy, & Zebit shares are racing higher

Atomos Ltd (ASX:AMS) and Galaxy Resources Limited (ASX:GXY) shares are two of four racing higher on Thursday...

Read more »

asx share price rise represented by red paper plane flying away from other white paper planes
Share Market News

Why the Bod (ASX:BDA) share price is rising 5% today

The Bod Australia Ltd (ASX: BDA) share price is climbing 5.7% higher as the company secured purchase orders for the…

Read more »

Share Market News

Why the BOD (ASX:BDA) share price is on the run today

The BOD Australia Ltd (ASX: BDA) share price is on the run today following a positive update from the company…

Read more »

cannabis leaves on a rising line graph representing growth of ASX cannabis share price
Share Market News

BOD (ASX:BDA) share price soars 8% on product launch

The Bod share price was flying today as the company announced its entrance into the Netherlands market. We take closer…

Read more »

wooden blocks with percentage signs being built into towers of increasing height
Share Market News

Bod share price surges 5% on record revenue growth

The Bod Australia Ltd (ASX: BDA) share price is surging today on positive numbers from the company's quarterly report. We…

Read more »

BOD ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
9th Apr 2025 2025-04-09T16:18:44 Long Term Suspended EntitiesYesNo4:18pm9210k
9th Apr 2025 2025-04-09T16:14:14 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo4:14pm71.3M
19th Mar 2025 2025-03-19T16:37:54 Notice to ShareholdersYesNo4:37pm1168k
24th Jan 2025 2025-01-24T15:49:09 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo3:49pm7530k
24th Jan 2025 2025-01-24T12:44:53 BOD Executes Asset Sale Deed to Sell IP RightsYesNo12:44pm2164k
22nd Jan 2025 2025-01-22T16:20:01 Long Term Suspended EntitiesYesNo4:20pm8206k
18th Dec 2024 2024-12-18T16:31:54 Notice to ShareholdersYesNo4:31pm1173k
12th Nov 2024 2024-11-12T15:07:57 Notification of cessation of securities - BODYesNo3:07pm413k
5th Nov 2024 2024-11-05T12:11:00 BOD Executes Binding Share Purchase AgreementYesNo12:11pm17381k
1st Nov 2024 2024-11-01T16:58:54 Appendix 4G and Corporate Governance StatementYesNo4:58pm24429k

About Bod Science Ltd

Bod Science Ltd. operates as a developer, manufacturer, distributor, importer, exporter and marketer of skincare, beauty, and health industries for the natural segment of the market. It operates through the following segments: OTC Medical, OTC CBD/Hemp, and Herbals. The company was founded by Joanne Patterson on August 13, 2014 and is headquartered in Double Bay, Australia.

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
02 Aug 2024 David Baker Expiry 937,500 $22,500
Options expired.
02 Aug 2024 Joanne (Jo) Patterson Cancelled 413,166 $9,915
As advised by the company. 696,273 LTI Rights
02 Aug 2024 George Livery Expiry 1,000,000 $24,000
Options expired.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr David Lewis Baker Non-Executive DirectorNon-Executive Chairman Apr 2022
Mr Baker is a commercial advisor and company director with over 40 years' experience in law, investment banking, public company leadership and corporate governance. He has industry knowledge across a range of sectors and a sophisticated understanding of financial markets. David is also a co-founder of Baker Cook Advisory which is a boutique provider of outsourced legal, commercial and governance advice and mediation services for corporations and government agencies. He is Chair of the Risk Committee.
Ms Joanne (Jo) Patterson Chief Executive OfficerExecutive Director Oct 2016
Ms Patterson has held multiple CEO and Managing Director roles over her career. She has more than 20 years of business experience in Australia and overseas. She has developed a number of businesses from start-up. She has also grown established organisations through mergers and acquisitions. The breadth of her commercial acumen is evidenced by her leadership of companies in the technology, advertising and beauty sectors. Her experiences led her to establish Bod in 2014 and then to subsequently list the business on the ASX in 2016.
Mr George Livery Non-Executive Director Sep 2018
Mr Livery has enjoyed senior executive roles across industries for the last 30 years, domestically and internationally as an expat. A C-level executive for the last 25 years, George's career has included CEO of Village Cinemas Australia, COO of Village International, Commercial Director at Hoyts Ltd, Director of Operations (Non Academic Services) at University of Sydney's USU, Commercial Director at Swisse Vitamins and Director of Strategy & Corporate at Swisse Wellness Group. Most recently George has enjoyed Chairperson, Non-executive Director and CoSec roles on ASX listed and private companies. George also led the corporate integration of Swisse Wellness into the Hong Kong listed H&H Group of companies and enjoyed a dual role during that time as Group Senior VP Legal and Risk. George has held board positions across a number of industries including the NFP sector. He is Member of the Risk Committee.
Mr Akash Bedi Non-Executive Director Jul 2019
Mr Bedi is the Chief Strategy and Operations Officer of Health & Happiness International Holdings Limited from December 2019. He joined the Group in July 2018 as Senior Director of Strategy and Corporate Affairs. As part of his role at the Group, Akash is responsible for overall procurement, logistics, production and supply chain for all H&H Group brands and is also responsible for developing business strategies and roadmaps, identifying growth opportunities and strengthening the Group's industry and market insight capabilities. In the last three years, he has been leading and managing the Swisse business for India and the Middle Eastern market. Akash also leads mergers and acquisitions for the Group and strategic investments for NewH2 Fund (the corporate venture subsidiary of the Group), which focuses on investing in global startups and growth companies with technologies and businesses of strategic importance. Prior to joining H&H, Akash held the position of Director, Global Consumer & Retail at HSBC for over 10 years from May 2008 where he worked on mergers and acquisition transactions from its global offices in New York, London and Hong Kong. Other current directorships: Else Nutrition Holdings, Inc. He is Member of the Risk Committee.
Ms Carlie Hodges Company Secretary Jan 2023
-
Adrian Sturrock Chief Financial Officer
-
Craig Weller Chief Technology Officer
-
Carlie Hodges Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 29,061,130 16.39%
Dutch Ink (2010) Pty Ltd 15,278,286 8.61%
Health And Beauty Enterprise Pty Limited 6,375,000 3.59%
Baker Cook Advisory <Baker Cook Super A/C> 6,375,000 3.59%
Noir Ted Pty Ltd 4,852,329 2.74%
Awj Family Pty Ltd <Aw Johnson Family A/C> 4,445,346 2.51%
Btt Sciences Ltd 3,750,000 2.11%
S3 Consortium Pty Ltd 3,535,112 1.99%
Gp Securities Pty Ltd 3,500,416 1.97%
Hendo Family Superannuation Pty Ltd <Henderson Superfund A/C> 2,235,295 1.26%
Avl Nominees Pty Ltd <Avl Holdings A/C> 2,000,000 1.13%
Biatan Pty Ltd <Mahoney Family A/C> 1,968,419 1.11%
Jimzbal Pty Ltd <Jimzbal Super A/C> 1,710,000 0.96%
Toucan Trading Pty Ltd 1,562,500 0.88%
Lake Pacific Pty Ltd 1,450,000 0.82%
Mrs Emma Isabell Nixon <Cicerm A/C> 1,203,209 0.68%
Vagg Family Pty Ltd 1,165,173 0.66%
Yoix Pty Ltd 1,010,000 0.57%
Mr Werner Josef Gallautz 1,000,000 0.56%
Mr Angus William Johnson and Mrs Lindy Johnson <The Denasuper Fund A/C> 961,084 0.54%

Profile

since

Note